Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment. - Wikidata - awgldk - TriplyDB

Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.

Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.

http://www.wikidata.org/entity/Q37373357

about

Pattern Recognition Receptors in Cancer Progression and Metastasis Emerging role of Toll-like receptor 4 in hepatocellular carcinoma Mucins and toll-like receptors: kith and kin in infection and cancer Cancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer control Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies The Role of Toll-Like Receptors in Hematopoietic Malignancies Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth Genomic profiling of thousands of candidate polymorphisms predicts risk of relapse in 778 Danish and German childhood acute lymphoblastic leukemia patients.Papilloma-pseudovirus eradicates intestinal tumours and triples the lifespan of ApcMin/+ mice.Combination antiretroviral therapy (cART) restores HIV-1 infection-mediated impairment of JAK-STAT signaling pathway.Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis Toll-like receptor transcriptome in the HPV-positive cervical cancer microenvironment Toll-like receptors and cancer, particularly oral squamous cell carcinoma.Should EMT of Cancer Cells Be Understood as Epithelial-Myeloid Transition?Genomic signatures of pregnancy-associated breast cancer epithelia and stroma and their regulation by estrogens and progesterone.Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study Gene expression analysis of peripheral blood cells reveals Toll-like receptor pathway deregulation in colorectal cancer Myeloid cell TRAF3 regulates immune responses and inhibits inflammation and tumor development in mice.TLR4 ligand/H₂O₂ enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways.Peroxiredoxin 1 controls prostate cancer growth through Toll-like receptor 4-dependent regulation of tumor vasculature Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome β-catenin promotes regulatory T-cell responses in tumors by inducing vitamin A metabolism in dendritic cells The expression of Toll-like receptor 8 and its relationship with VEGF and Bcl-2 in cervical cancer.Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice.Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous niche A Prospective Evaluation of the Association between a Single Nucleotide Polymorphism rs3775291 in Toll-Like Receptor 3 and Breast Cancer Relapse Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma.Radiation takes its Toll TLR3-Induced Maturation of Murine Dendritic Cells Regulates CTL Responses by Modulating PD-L1 Trafficking.T lymphocytes and normal tissue responses to radiation.TRAF3: a novel tumor suppressor gene in macrophages.Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans.Acute inflammation induces immunomodulatory effects on myeloid cells associated with anti-tumor responses in a tumor mouse model.TLR4 signaling promotes a COX-2/PGE2/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells.TLR7 Gln11Leu single nucleotide polymorphism and susceptibility to cutaneous melanoma Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab.B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma.IRAK4 and TLR3 Sequence Variants may Alter Breast Cancer Risk among African-American Women Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins

P2860

Q26798034-4C5A8D25-653F-4AFD-87F4-191D31C1ECD1 Q26824613-E9ADFCD8-DB97-4A78-85D3-F2EA61D35E1C Q26830597-0EBD34D4-89E0-4F6E-B3B3-A8C12CC26420 Q26860058-74857A68-09D6-4BE5-B39C-1CA6E13E925B Q26861234-2AFDAFA2-CD42-4E0C-ABBD-A9B2AEDA6B31 Q28077740-78414C77-E85D-4B7C-8D3C-A328D4CC07A9 Q30842176-4EEB853D-7133-4ACD-83D6-9B61EEFE88AF Q31170949-A15BA784-9000-4B1C-8B9D-14472DCC4036 Q33571959-3303CE3C-8729-4B5F-ACFF-6EF2A6D689DB Q33618390-E16FDA7B-1FA6-4E15-856C-2FE16B2497A2 Q33762632-CC30ED8B-7A3D-4C11-B4A0-490DB0D27FF8 Q34052237-B98FBB5A-9D8D-41E9-9304-DA74D371DA7E Q34239239-F72C7132-5B86-4EA7-A17F-EC4816984189 Q34402141-1B092615-3575-4F80-BED2-78D59EC5610F Q34616439-FA57699B-803A-4137-A97F-6E9F274E83B9 Q34698854-15FE78D4-5375-4CE3-9747-4635545ACF09 Q34708456-07CE4031-24C9-4689-B884-FB6B024178E6 Q34749424-9EFC032E-D7EB-481E-AEB0-10C8D8295DFA Q34756109-FA44E39A-F6CD-4EC9-AAC0-DD42D21EE038 Q34793013-615771F0-4648-4979-8410-F613FB001324 Q35023463-14C9BE46-F5A7-4A1F-8221-C216312D0A25 Q35096982-B894F9BB-CA71-4F2C-A3E5-3837C73DFFE7 Q35159974-B031DD78-691B-4C18-84D4-5B476AC2C6C5 Q35606746-51FD0AEE-21A0-4220-856A-B611591E8429 Q35717532-A1F66899-1755-49D6-B473-6BED102AF18E Q35726685-78C67FEE-7CDD-4B1B-A15C-A1EE708C068E Q35833184-5B59867E-59EE-4149-A52A-CD7994BC3992 Q36083353-A084F2F9-A99D-4AA4-87B8-575CDC901A39 Q36212034-600BD9D8-7538-4AB4-8C73-C31FF5426DFD Q36244299-3D5FB412-02E1-4F11-8928-D38C3767A070 Q36357661-62AFDAB7-870B-4DA9-818B-3A7E70943AD0 Q36357873-6CF8BF09-CC1A-4283-9661-B606CD178559 Q36620354-D13EE9CE-00FB-412F-BABB-C264EB8FA9C6 Q36710952-FF871284-1B82-46DB-84ED-A85842EDDD2A Q37001734-EC577AF3-9BB7-405C-BA88-D395408A0779 Q37075302-9E94C320-4237-43BC-848F-370031B7A342 Q37140050-0BF9F19B-D470-4C11-B47A-E4E9DE335326 Q37261748-BFF1208B-0F5C-44AC-94A7-9C5DD554BA8D Q37291780-124373DF-EDB3-4E50-95B0-AA16AB345A2A Q37396607-A11B52A4-D1FC-4971-9AB5-6820F42783B2

P2860

Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.

http://www.wikidata.org/entity/Q37373357

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.

@en

Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.

@nl

type

label

Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.

@en

Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.

@nl

prefLabel

Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.

@en

Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.

@nl

P1433

Q37373357-72773813-3503-4AAD-9DD2-CCD72F3A309C

P1476

Q37373357-C353BDF6-E1D6-4B90-B054-D000AE73196F

P2093

Q37373357-012F353F-DB0D-455D-BC1A-58CA517AFAA4

Q37373357-07806C0C-405D-4C60-8608-7708998533ED

Q37373357-AEC6199A-40C0-4543-9B07-6F0A0798DF0C

Q37373357-B121A3F2-09F3-4D75-B7FF-BEFA0F8666EF

P2860

Q37373357-002690BD-F612-447D-B4E9-90912F5175BF

Q37373357-0759F679-A369-4E1D-8D8E-BA0644ADEABE

Q37373357-08B7C052-C75E-40A2-93A8-953EB77B0137

Q37373357-08FC6D08-1061-4836-840B-CA53E879C92C

Q37373357-0B17585C-9570-46A6-AAD5-A524E4010003

Q37373357-0B9BFB9D-0B3E-48F1-B7EF-97E09BE8DF2F

Q37373357-103DBD81-4290-4523-A0FC-081D04F359E7

Q37373357-12890B07-4BDA-4D1C-976A-C0F70123BCDB

Q37373357-183EFF49-D1DB-419C-A30F-85F6AFE213CA

Q37373357-190180C3-88FA-4EAD-9E4F-D9E730228474

P2888

Q37373357-2E8D49C8-794D-4756-88C0-39F13757486A

P304

Q37373357-E4CFC648-1A22-4461-AB71-7E2C38D081FB

P31

Q37373357-AA01EE2F-8338-4871-B4BF-3879BCD370DB

P356

Q37373357-7377C53C-372C-4228-8B56-02EA2464A561

P478

Q37373357-BBEEB273-195A-4B34-A2FA-0013FC39EBC7

P577

Q37373357-23A137AA-BD9D-414F-8311-1BEB11C21305

P5875

Q37373357-564BD225-83B2-4BD5-A447-1F58CE9AA4D5

P698

Q37373357-92F13B44-589A-44E7-825E-4388F623A379

P921

Q37373357-DA9595E9-6A7E-44CA-8160-51F04005BF70

P932

Q37373357-275EB999-B1A0-4739-B2D4-A3D06589745E

P356

S12307-009-0022-Y

P1433

Cancer microenvironment : official journal of the International Cancer Microenvironment Society

P1476

Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.

@en

P2093

Dave S B Hoon

http://www.w3.org/2001/XMLSchema#string

Norihiko Narita

http://www.w3.org/2001/XMLSchema#string

Yasufumi Goto

http://www.w3.org/2001/XMLSchema#string

Yusuke Sato

http://www.w3.org/2001/XMLSchema#string

P2860

Human lung cancer cells express functionally active Toll-like receptor 9

HMGB1 mediates endogenous TLR2 activation and brain tumor regression

Cancer-related inflammation

Imiquimod applied topically: a novel immune response modifier and new class of drug

Increased toll-like receptor 9 expression in cervical neoplasia

Masquerader: high mobility group box-1 and cancer

The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase

Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

Macrophage activation and polarization

P2888

s12307-009-0022-y

P304

205-214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12307-009-0022-Y

http://www.w3.org/2001/XMLSchema#string

P478

2 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26746430

http://www.w3.org/2001/XMLSchema#string

P698

19685283

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

2756339

http://www.w3.org/2001/XMLSchema#string